Showing 81 - 100 results of 33,995 for search '(( significant ((small increased) OR (small decrease)) ) OR ( significant clinical decrease ))', query time: 0.33s Refine Results
  1. 81
  2. 82

    Table1_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.DOCX by Zabed Mahmud (12827819)

    Published 2022
    “…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
  3. 83

    Image1_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf by Zabed Mahmud (12827819)

    Published 2022
    “…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
  4. 84

    Image3_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf by Zabed Mahmud (12827819)

    Published 2022
    “…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
  5. 85

    Image2_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf by Zabed Mahmud (12827819)

    Published 2022
    “…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
  6. 86

    Significant condition. by Junxia Zhou (14381598)

    Published 2024
    “…Over time, the content of C-A-H stabilized at 22%, the amount of CH decreased from 19% to 14%, whereas the amount of AFt increased to 15.9% by Day 28. …”
  7. 87
  8. 88
  9. 89

    Table_3_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  10. 90

    Image_5_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  11. 91

    Image_4_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  12. 92

    Image_2_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  13. 93

    Table_2_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  14. 94

    Image_1_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  15. 95

    Image_3_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  16. 96

    Table_1_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx by Zhixing Hao (11957489)

    Published 2022
    “…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
  17. 97
  18. 98

    Revealing Deformation Mechanisms in Polymer-Grafted Thermoplastic Elastomers via <i>In Situ</i> Small-Angle X‑ray Scattering by Vincent M. Torres (17125253)

    Published 2023
    “…The neat SBS (φ<sub>SBS</sub> = 100%) sample deforms congruently with the macroscopic dimensions, with the domain spacing between spheres increasing and decreasing along and transverse to the stretch direction, respectively. …”
  19. 99

    Revealing Deformation Mechanisms in Polymer-Grafted Thermoplastic Elastomers via <i>In Situ</i> Small-Angle X‑ray Scattering by Vincent M. Torres (17125253)

    Published 2023
    “…The neat SBS (φ<sub>SBS</sub> = 100%) sample deforms congruently with the macroscopic dimensions, with the domain spacing between spheres increasing and decreasing along and transverse to the stretch direction, respectively. …”
  20. 100